Dynamic Medical Technologies Inc. · TPEX:4138
Dynamic Medical Technologies — Investor Conference April 2022
41 slides from Dynamic Medical Technologies's conference presentation, Apr 24, 2022
Slide 1: Investor Conference
April 24, 2022 Symbol:4138 Investor Conference 1
Slide 2: Disclaimer
Disclaimer This presentation is prepared according to the reviewed financial statements by CPA and the financial numbers hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ materially f
Slide 3: Content
1.公司概況(Corporate Overview) 2.市場概況(Market Overview) 目錄 3.營運概況(Business Overview) Content 4.財務概況(Financial Overview) 5.策略及展望(Strategies and Outlook) 6.補充資料(Appendix) 3
Slide 4: 1. Corporate Overview
1.公司概況(Corporate Overview) 4
Slide 5: Corporate Overview: Chairman and mission
公 司 概 況 曜亞國際 •從台灣出發、 『光曜亞洲、放眼國際』 經營理念 •客戶滿意．快樂員工．幸福企業 ．美麗人生 使命 •誠信正直 團隊合作 當責創新 董事長 Chairman 傅輝東 Tony Fu 5
Slide 6: Top Provider of Medical Aesthetic Solutions in Asia
Top Provider of Medical Aesthetic Solutions in Asia Beauty medical equipment Excelsior Fitness shaping Beauty Scalp care Overseas DMT Scalp care after Pregnant Beauty medical equipment DMT Fitness shaping of LPG Aesthetic Consumables CYJ from France Hydra touch H2 Dermal Filler DRCYJ clean & care 6
Slide 7: DMT's Products Portfolio
DMT’s Products Portfolio Energy- Based Device Home-Use Beauty RF & HIFU Device 曜亞 Dermal Body Filler Contouring Skin/ hair Neurotoxin Care 7
Slide 8: Create a beauty life map
Crate a beauty life map Area 佳美(EB) / CYJ 2022 Expand Business North 11 5 area Middle 2 1 area South 4 1 area Total 17 7 Expand Business CYJ(台北內湖) CYJ(永和頂溪) CYJ(台南永康) CYJ(台北中山) CYJ(新竹立鵬) CYJ(林口文化) CYJ(台中中友) 8
Slide 9: 2. Market Overview
目錄 Content 2.市場概況(Market Overview) 9
Slide 10: Market Overview
Market Overview According to the Asian-Pacific Market Study Product Portfolio issued by Medical Insight, Inc. in Mar. 2022, total Asian sales of all aesthetic products and equipment reached US$2.7 billion in 2020 and are expected to increase by 16.4% per year through 2025. Furthermore, medical aesth
Slide 11: Taiwan Market Overview
Taiwan Market Overview Severe New competition Technology among the is the king Aesthetic Industry Intensive Marketing prevail Channel/ Chains of Supplier Aesthetic Clinics integration are powerful 11 11
Slide 12: Operating Superiority
Operating Superiority Complete aesthetic The Company will To make facial and body treatments Diversified facial continue to develop medicine more comprehensive injectables to satisfy and introduce consumable line, and to provide comprehensive products that meet comprehensive one- superior services t
Slide 13: 3. Business Overview
3.營運概況(Business Overview) 13
Slide 14: Business Overview: Revenue by product ratio
Business Overview Unit：NTD$K DMT Revenue by product ratio 1,400,000 1,164,815 1,178,195 1,200,000 154,154 1,009,308 1,028,183 13% 185,251 16% 1,000,000 209,188 237,148 800,000 627,437 557,842 54% 47% 600,000 21% 547,915 613,333 23% 400,000 54% 200,000 383,224 435,102 37% 60% 33% 252,205 25% 177,702
Slide 15: Operating Revenue
Unit：NTD$K 180,000 40.00% Operating Revenue 157,823 160,418 160,000 38.00% 1,400,000 140,848 140,000 133,005 36.00% 1,164,815 1,178,195 1,200,000 34% 34.00% 131,105 183,588 16% 1,009,308 1,028,183 120,000 11% 32% 1,000,000 32.00% 118,712 100,000 237,688 20% 10% 240,829 24% 308,464 30% 30.00% 800,000
Slide 16: 4. Financial Overview
4.財務概況(Financial Overview) 16
Slide 17: Financial Overview
380,000 40.00% 354,582 Consolidated Gross 360,000 38.00% Financial Overview Unit：NTD$K Profit 340,000 336,258 334,168 318,042 36.00% 34% 34.00% 320,000 Consolidated 32% 32.00% 1,164,815 1,178,195 300,000 Operating Revenue 29% 30.00% 1,009,308 1,028,183 280,000 28% 28.00% 260,000 26.00% 240,000 24.00
Slide 18: Profit Before Income Tax, Net Profit, EPS
Net Profit for the year Profit Before Income Tax Unit：NTD$K Unit：NTD$K 160,000 200,000 140,000 18,483 180,000 120,000 13,551 647 13,403 17,307 160,000 2,152 100,000 7,842 140,000 9,418 80,000 120,000 60,000 115,995 123,206 104,975 112,521 100,000 40,000 80,000 157,823 160,418 20,000 133,005 140,848
Slide 19: 5. Strategies and Outlook
5.策略及展望(Strategies and Outlook) 19
Slide 20: Future Prospects
Future Prospects Long-Term Planning Southeast Asia Market Strategic Alliance Market leader Mid-Term Planning New Product Development Preventive Medicine Lifestyle Beauty Device Aesthetic Consumables Short-Term Planning Body Contouring Market Launching Cosmetic Neurotoxin: Developme
Slide 21: Body shaping devices, dermal filler, neurotoxins
Body shaping devices Dermal filler Energy-based cosmetic Devices neurotoxins Brand Maintenance Channel 21
Slide 22: Market is Growing
Market is Growing Market is Growing Aesthetic Collagen- Laser LPG RF stimulating Dr. CYJ Gel Form HA Ultrasound Cryolipolysis ParticlCe Form Excelsior HA Beauty Daily Clinics Beauty Build Muscle Neurotoxin Body shaping devices Dermal filler/cosmetic neurotoxins 22
Slide 23: ° MMe
© RC MANBE SOS © GS eA) A eet ° MMe © SSMS S ER ° HERBS SERIE PRES ANE qt DISH TORRSARASBD SUN AR BMRA SCARAB AN REESE AR AAD 7) BA 32 8D NPD 68 (=) REAR
Slide 24: Neuronox
Neuronox 高純度 肉毒桿菌素注射劑 高強度菌株 高效力高安全性 國際性品牌 24 24
Slide 25: 25
25
Slide 26: 2022's New Arrival
2022’S New Arrival DR CYJ 胜肽恆燦護色系列 永恆璀璨 閃耀光彩 針對經常染燙 需要護色 易毛躁打結 無光澤髮所設計 26
Slide 27: Classroom online
Classroom online 27
Slide 28: Classroom online
2021 TDAP ZX New player, New option- Glabella lines treatment by-Neuronox | handpieces light up,the way to mal picosecond laser treatment eit ', How to optimize owrstuiio -* 12:30-13:00 (Medytox) ™ collagen stir Nai-Jen Hsu, MD . | wai ', Ay |, : 13:30-14:00 DMT Studio 13:00-13:30 BStheFilll fH | Ch
Slide 29: Classroom online
Classroom online oa \ NS BA PicoWay ip F I Dae > MS AAR ? ane @ > SARASRRRD ? I 1 2a > REA ARR ? > RSMAS M RRS ? ZRF EAR @ GotoWebinar 730nm & Fusion 532. NEW ARRIVAL Bam 88 BES CANDELA = @ mesures
Slide 30: CYJ Hair Centre~ Vip room
CYJ Hair Centre~ Vip room(Independent,Private) 30 30
Slide 31: Blogger's share
Blogger’s share Angelina Liu (22%)
Slide 32: CYJ Hair Centre
CYJ Hair Centre a’ 4 Ueluaecn nnmwua SERRA unseen cam woes mga et a ee imag, WlGuoCeT LEARY FE NOTRE AIOE CARRE E05 G22 SRS @® DMT
Slide 33: 6. Appendix
6.補充資料(Appendix) 33
Slide 34: Balance sheet: assets
Unit：NTD$K 2019/12/31 2020/12/31 2021/12/31 Cash and cash equivalents 681,226 784,901 813,371 Debt investments with no active market - current 468,649 447,351 492,091 Notes receivable & Trade receivables 166,001 134,837 133,539 Inventories 229,816 147,124 170,233 Other current assets 19,759 22,959 3
Slide 35: Balance sheet: liabilities and equity
Unit：NTD$K 2019/12/31 2020/12/31 2021/12/31 Notes payable & Trade payables 58,818 27,101 61,554 Other payables 185,019 152,170 134,488 long-term liabilities-current portion contract liability 295,460 306,505 375,255 Other current liabilities 81,208 69,894 86,258 Total current liabilities 620,505 555
Slide 36: Income statement
Unit：NTD$K 2019 2020 2021 AMT % AMT % AMT % OPERATING REVENUE 1,178,195 100.00 1,009,308 100.00 1,028,183 100.00 OPERATING COSTS 844,027 71.64 691,266 68.49 673,601 65.51 GROSS PROFIT 334,168 28.36 318,042 31.51 354,582 34.49 OPERATING EXPENSES 176,345 14.97 177,194 17.56 194,164 18.88 PROFIT FROM O
Slide 37: Cash flows from operating activities
Unit：NTD$K 2019 2020 2021 Cash flows from operating activities: Profit before tax 159,975 148,690 173,821 Total adjustments to reconcile profit 72,554 80,264 88,856 Accounts receivable 43,993 35,386 (5,416) Other receivable (457) 646 (29) Inventories 78,140 63,893 (52,459) Accounts payable (21,036)
Slide 38: Cash flows from investing activities
Unit：NTD$K 2019 2020 2021 Cash flows from investing activities: Acquisition of financial assets at amortised cost (348,649) (246,501) (268,491) Proceeds from disposal of financial assets at amortised cost 60,000 267,799 223,751 Acquisition investments in debt instrument without active - - - market P
Slide 39: Cash flows from financing activities
Unit：NTD$K 2019 2020 2021 Cash flows from financing activities: Repayments of bonds - - - Cash dividends paid (94,500) (100,500) (105,000) Acquisition of ownership interests in subsidiaries - - - Other (43,417) (50,943) (43,680) Net cash flows used in financing activities (137,917) (151,443) (148,68
Slide 40: On the Top, Aiming High
On the Top, Aiming High Accumulated years of experience, DMT. is in the leading edge of the medical aesthetic market by means of sophisticated sales and marketing forces and dedicated service and management team. With successful integration, DMT has achieved vertical integration of medical aesthetic
Slide 41: Dynamic Medical Technologies Inc.
@ wes CYNAMIC MEDICAL TECHNOLOGIES INC. | DRAGER RRHE | BRRERERR | BATRA | BOHRATERE | SRRBEARHE | international medical aesthetics equipment selling Medical aesthetics equipmert naintenance Dermal filler selling ntegraved marketing services for medical aesthetics
Dynamic Medical Technologies — Investor Conference April 2022 on 6ix